{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T05:32:44Z","timestamp":1738992764495,"version":"3.37.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1097\/wnf.0b013e31805751a3","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T23:55:28Z","timestamp":1236210928000},"page":"357-361","source":"Crossref","is-referenced-by-count":4,"title":["Ziprasidone-Associated Depressive State in Schizophrenic Patients"],"prefix":"10.1097","volume":"30","author":[{"given":"Alexander","family":"Kaptsan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzvi","family":"Dwolatzky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210203","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0010-440X(88)90062-4","article-title":"Depressive symptoms in schizophrenia: comprehensive differential diagnosis.","volume":"29","author":"Bartels","year":"1988","journal-title":"Compr Psychiatry"},{"key":"R2-6-20210203","first-page":"224","article-title":"Medication as a potential cause of depression.","volume":"70","author":"Gangat","year":"1986","journal-title":"S Afr Med J"},{"key":"R3-6-20210203","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2165\/00002512-199303020-00005","article-title":"Drug-induced depression in the aged. What can be done?","volume":"3","author":"Ganzini","year":"1993","journal-title":"Drugs Aging"},{"key":"R5-6-20210203","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1176\/ajp.155.11.1490","article-title":"Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings.","volume":"155","author":"Dalack","year":"1998","journal-title":"Am J Psychiatry"},{"key":"R7-6-20210203","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4088\/JCP.v58n1004","article-title":"Pimozide-induced depression in men who stutter.","volume":"58","author":"Bloch","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"R8-6-20210203","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0924-9338(99)00228-X","article-title":"Dysphoric subjective response to neuroleptics in schizophrenia: relationship to extrapyramidal side effects and symptomatology.","volume":"14","author":"Gervin","year":"1999","journal-title":"Eur Psychiatry"},{"key":"R9-6-20210203","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/schbul\/19.3.609","article-title":"Subjective response to neuroleptics in schizophrenia.","volume":"19","author":"Awad","year":"1993","journal-title":"Schizophr Bull"},{"key":"R10-6-20210203","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/schbul\/8.1.109","article-title":"Depressive states occurring during the neuroleptic treatment of schizophrenia.","volume":"8","author":"Moller","year":"1982","journal-title":"Schizophr Bull"},{"key":"R12-6-20210203","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/10401230490281410","article-title":"Atypical antipsychotics in the treatment of affective symptoms: a review.","volume":"16","author":"Masan","year":"2004","journal-title":"Ann Clin Psychiatry"},{"key":"R13-6-20210203","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4088\/JCP.v65n0212","article-title":"Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder.","volume":"65","author":"Papakostas","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R14-6-20210203","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.4088\/JCP.v63n1115","article-title":"Depression and dysphoria in adult and adolescent patients with Tourette's disorder treated with risperidone.","volume":"63","author":"Margolese","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R15-6-20210203","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/01.wnf.0000162172.51547.53","article-title":"Quetiapine-associated depression in a patient with schizophrenia.","volume":"28","author":"Mergui","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"R16-6-20210203","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF02195978","article-title":"Depressive syndromes in schizophrenic patients under neuroleptic therapy. ANI Study Group Berlin, Dusseldorf, Gottingen, Munich, Federal Republic of Germany.","volume":"241","author":"Bandelow","year":"1992","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R17-6-20210203","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/schbul\/20.2.327","article-title":"Depression in schizophrenia: are neuroleptics, akinesia, or anhedonia involved?","volume":"20","author":"Harrow","year":"1994","journal-title":"Schizophr Bull"},{"issue":"suppl 3","key":"R18-6-20210203","first-page":"115","article-title":"How to distinguish between the neuroleptic-induced deficit syndrome, depression and disease-related negative symptoms in schizophrenia.","volume":"10","author":"Barnes","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"key":"R19-6-20210203","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-3565(25)12023-5","article-title":"Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.","volume":"275","author":"Seeger","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"R20-6-20210203","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0893-133X(99)00057-3","article-title":"Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine: inhibition of dorsal raphe cell firing and the role of 5-HT1A receptor activation.","volume":"21","author":"Sprouse","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"R21-6-20210203","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0024-3205(00)00911-5","article-title":"Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds.","volume":"68","author":"Richelson","year":"2000","journal-title":"Life Sci"},{"key":"R22-6-20210203","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0022-3565(24)38891-3","article-title":"Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors.","volume":"295","author":"Herrick-Davis","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"R23-6-20210203","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0006-3223(00)00850-7","article-title":"5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex.","volume":"48","author":"Rollema","year":"2000","journal-title":"Biol Psychiatry"},{"key":"R24-6-20210203","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-1781(97)03076-X","article-title":"Effect of neuroleptic treatment on depressive symptoms in acute schizophrenic episodes.","volume":"71","author":"Krakowski","year":"1997","journal-title":"Psychiatry Res"},{"key":"R25-6-20210203","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","article-title":"Dopamine in schizophrenia: a review and reconceptualization.","volume":"148","author":"Davis","year":"1991","journal-title":"Am J Psychiatry"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002826-200711000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:56:39Z","timestamp":1738976199000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-200711000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e31805751a3","relation":{},"ISSN":["0362-5664"],"issn-type":[{"type":"print","value":"0362-5664"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}